Search results
Eli Lilly exec expects obesity pill data in April 2025
WHTC 1450 Holland· 3 days ago(Reuters) - Data from Eli Lilly's late stage trial on experimental obesity pill orforglipron is...
Weight loss surgery more effective than obesity drugs, diet changes: study
NY Post via Yahoo News· 3 days ago"Surgery needs to play a bigger role in obesity treatment and be considered earlier in the disease...
Avidity drug for muscular dystrophy shows promise; Syntis takes new approach to weight loss
BioPharma Dive via Yahoo Finance· 2 days agoStudy results indicated Avidity’s medicine muted target genes. Elsewhere, Syntis revealed obesity ...
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters· 10 hours agoAbout one-third of U.S. employer health plans are offering coverage of GLP-1 drugs for both diabetes...
Around 42 Percent Of Those Aged 20 And Above In The US Are Obese, Yet GLP-1 Weight Loss Drugs Are...
Wccftech· 2 days agoWall Street is convinced that anti-obesity GLP-1 drugs constitute a thematic bull case, with Goldman...
Structure Therapeutics (GPCR) Rallying on Obesity Drug Data
Zacks via Yahoo Finance· 3 days agoStructure Therapeutics (GPCR) stock sees an upside on positive top-line data from a phase IIa ...
Kansas City lawyer becomes co-lead counsel in national weight-loss drug lawsuit - Kansas City...
The Business Journals· 10 hours agoA Kansas City lawyer is helping lead a class-action lawsuit against Novo Nordisk and Eli Lilly,...
Eli Lilly exec says seeing out of pocket payments for obesity drug in US
WHTC 1450 Holland· 3 days ago(Reuters) - A top Eli Lilly executive said on Monday that more patients are paying the full list...
Pre-operative use of GLP-1s may reduce complications after metabolic, bariatric surgery in patients...
Medical Xpress· 19 hours agoA combination of GLP-1 agonists taken before metabolic and bariatric surgery may help patients with...
Eli Lilly Hits an All-Time High: Is the Soaring Pharma Stock Still a Buy?
Motley Fool via Yahoo Finance· 3 days agoAnalysts project peak risk-adjusted annual sales of the drug could easily top $5 billion. Lilly's...